Compare InMode Ltd (INMD) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs Koninklijke Philips NV — how do they compare? InMode Ltd trades at $15.38 (market cap $882.90M), while Koninklijke Philips NV trades at $26.77 (market cap $26.19B). The key difference: Koninklijke Philips NV is far larger — about 29.7× InMode Ltd's market cap, and Koninklijke Philips NV pays a 3.79% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.
| INMD | PHG | |
|---|---|---|
Market Cap | $882.90M | $26.19B |
Sector | Technology | Health |
52-Week High | $16.62 | $32.91 |
52-Week Low | $12.76 | $24.54 |
Enterprise Value | $350.57M | $32.46B |
Dividend Yield | — | 3.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INMD trades at $15.36, down 0.71% on the day, with a bullish technical signal and strong profitability metrics including a 77.84% gross margin and 23.27% net margin. Recent news includes an unsolicited acquisition offer of $16.75 per share from Steel Partners and Q2 2026 revenue guidance of $95.2M-$95.4M. The stock shows robust cash flow generation with $147.21M net cash flow in 2025.
The outlook is mixed with solid fundamentals and acquisition interest providing upside potential, but Q1 2026 earnings miss and ongoing securities fraud investigations pose risks. Analyst consensus is a $16.50 price target with a balanced buy/hold rating split, suggesting cautious optimism amid corporate developments.
PHG trades at $26.58, down 1.37% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported net income of $895 million in 2025, a significant recovery from prior losses, with a net margin of 5.5%. Recent FDA clearances for medical devices and AI integrations highlight ongoing innovation. Cash flow from operations remains positive at $1.17 billion for 2025, though net cash flow declined to $403 million.
The outlook is mixed: analyst consensus is neutral with 59% hold ratings, reflecting caution despite recent profitability improvements. Key risks include high debt levels, with debt-to-asset ratio at 25.44% in 2025, and competitive pressures in health technology. Upside potential hinges on execution of AI-driven growth initiatives and margin expansion, as noted in Seeking Alpha analysis on 2026-05-20.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
